"Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate

Sagel U, Krämer A, Mikolajczyk RT (2012)
BMC Infectious Diseases 12(1): 118.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ;
Abstract / Bemerkung
Recent studies from Austria, France and Italy have shown that there is a poor adherence to the screening scheme for maternal Toxoplasma infections in pregnancy demonstrated by the fact that many recommended examinations are missed. This leads to undetected infections and limits our knowledge of incidence of the disease. We discuss the negative consequences of this situation on research on treatment effectiveness and the outcomes of congenital toxoplasmosis. The responsible public health institutions should assume responsibility for appropriate surveillance of the screening programme and take measures to improve screening adherence during pregnancy. Screening should start as early as possible in pregnancy and the latest test should be done at delivery. Screening schedule should allow distinguishing infections from the first, second and third trimester of pregnancy, as the risk of materno-foetal transmission and outcomes in case of foetal infections varies by time.
Erscheinungsjahr
Zeitschriftentitel
BMC Infectious Diseases
Band
12
Zeitschriftennummer
1
Seite
118
ISSN
PUB-ID

Zitieren

Sagel U, Krämer A, Mikolajczyk RT. "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases. 2012;12(1):118.
Sagel, U., Krämer, A., & Mikolajczyk, R. T. (2012). "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases, 12(1), 118. doi:10.1186/1471-2334-12-118
Sagel, U., Krämer, A., and Mikolajczyk, R. T. (2012). "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases 12, 118.
Sagel, U., Krämer, A., & Mikolajczyk, R.T., 2012. "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases, 12(1), p 118.
U. Sagel, A. Krämer, and R.T. Mikolajczyk, “"Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate”, BMC Infectious Diseases, vol. 12, 2012, pp. 118.
Sagel, U., Krämer, A., Mikolajczyk, R.T.: "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases. 12, 118 (2012).
Sagel, Ulrich, Krämer, Alexander, and Mikolajczyk, Rafael T. “"Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate”. BMC Infectious Diseases 12.1 (2012): 118.

1 Zitation in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.
Lykins J, Wang K, Wheeler K, Clouser F, Dixon A, El Bissati K, Zhou Y, Lyttle C, Rzhetsky A, McLeod R., Clin Infect Dis 63(4), 2016
PMID: 27353665

28 References

Daten bereitgestellt von Europe PubMed Central.

Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R., Lancet 353(9167), 1999
PMID: 10359407
Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis.
Chene G, Thiebaut R., Mem. Inst. Oswaldo Cruz 104(2), 2009
PMID: 19430657
Infection with Toxoplasma gondii during pregnancy [German]
AUTHOR UNKNOWN, 2005

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 22591211
PubMed | Europe PMC

Suchen in

Google Scholar